The centers will be administering the FDA approved iCAT treatment for diabetes and related wound care for Type 1 and Type 2 diabetes patients. These are the first of a series of centers to be opened in the midwest of the US.
Jimmy McDougald, CEO of VitalCare, said: “This is the beginning of our midwest launch and we are excited to be offering iCAT therapy to diabetics in this region.”